Brain Tumors in Adults

We take on the most difficult to treat brain tumors, including glioblastomas, gliomas, astrocytomas, meningiomas, and metastatic brain tumors. We’re nationally known for providing innovative precision molecular diagnoses for brain tumors, and for our expertise in neurosurgery, neuro-oncology, and Gamma Knife®, a precisely targeted radiation treatment for complex brain tumors. We believe that, in some cases, the standard of care may be outdated and might not be the best treatment for you. That’s why we base your care plan on the tumor’s precise molecular makeup, delivering truly individualized care with compassion. We also design cutting-edge clinical trials to find promising new treatments.

Clinical Trials and Research Studies

Phase 3

HEAD START 4: NEWLY DIAGNOSED CHILDREN (LESS THAN 10 YEARS OLD) WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS

Learn More

Phase 1

A Phase 1 Open-Label Study of the Safety Tolerability and Efficacy of KPT-9274 A Dual Inhibitor of PAK4 and NAMPT in Patients with Advanced Solid Malignancies or Non-Hodgkin's Lymphoma (PANAMA)

Learn More

Phase 2

PHASE II TRIAL OF SMO/AKT/NF2 INHIBITORS IN PROGRESSIVE MENINGIOMAS WITH SMO/AKT/NF2 MUTATIONS

Learn More

Phase 2

Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases

Learn More